47. Semin Oncol. 2017 Aug;44(4):286-287. doi: 10.1053/j.seminoncol.2017.10.011. Epub 2017 Oct 31.Bevacizumab in breast cancer: a targeted therapy still in search of a targetpopulation.Marks DK(1), Kalinsky K(2).Author information: (1)Department of Medicine, College of Physicians and Surgeons, ColumbiaUniversity Medical Center, New York, NY; Herbert Irving Comprehensive CancerCenter, Columbia University, New York, NY.(2)Department of Medicine, College of Physicians and Surgeons, ColumbiaUniversity Medical Center, New York, NY; Herbert Irving Comprehensive CancerCenter, Columbia University, New York, NY. Electronic address:kk2693@columbia.edu.DOI: 10.1053/j.seminoncol.2017.10.011 PMID: 29526257 